These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Glycyrrhizin inhibits influenza A virus uptake into the cell. Wolkerstorfer A; Kurz H; Bachhofner N; Szolar OH Antiviral Res; 2009 Aug; 83(2):171-8. PubMed ID: 19416738 [TBL] [Abstract][Full Text] [Related]
45. Inhibition of Epstein-Barr virus replication by small interfering RNA targeting the Epstein-Barr virus protease gene. Larrat S; Morand P; Bas A; Vigne S; Crance JM; Boyer V; Nicod S; Grossi L; Buisson M; Burmeister WP; Seigneurin JM; Germi R Antivir Ther; 2009; 14(5):655-62. PubMed ID: 19704168 [TBL] [Abstract][Full Text] [Related]
46. Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro. Baba M; Shigeta S Antiviral Res; 1987 Feb; 7(2):99-107. PubMed ID: 3034150 [TBL] [Abstract][Full Text] [Related]
47. Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV. Church TM; Verma D; Thompson J; Swaminathan S J Virol; 2018 Mar; 92(6):. PubMed ID: 29263273 [TBL] [Abstract][Full Text] [Related]
48. Structure-activity relationship between (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BV-araU, V-araU) in inhibition of Epstein-Barr virus replication. Lin JC; Reefschläger J; Herrmann G; Pagano JS Antiviral Res; 1992 Jan; 17(1):43-52. PubMed ID: 1310582 [TBL] [Abstract][Full Text] [Related]
49. Maribavir inhibits epstein-barr virus transcription in addition to viral DNA replication. Wang FZ; Roy D; Gershburg E; Whitehurst CB; Dittmer DP; Pagano JS J Virol; 2009 Dec; 83(23):12108-17. PubMed ID: 19759127 [TBL] [Abstract][Full Text] [Related]
50. Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV). Ito M; Sato A; Hirabayashi K; Tanabe F; Shigeta S; Baba M; De Clercq E; Nakashima H; Yamamoto N Antiviral Res; 1988 Dec; 10(6):289-98. PubMed ID: 3250333 [TBL] [Abstract][Full Text] [Related]
51. Partial elimination of latent Epstein-Barr virus genomes from virus-producing cells by cyclohexamide. Tanaka A; Nonoyama M; Hampar B Virology; 1976 Mar; 70(1):164-70. PubMed ID: 176800 [No Abstract] [Full Text] [Related]
52. Inhibition of productive replication of Epstein-Barr virus DNA by phosphonoacetic acid. Yajima Y; Tanaka A; Nonoyama M Virology; 1976 May; 71(1):352-4. PubMed ID: 179207 [No Abstract] [Full Text] [Related]
53. Esters of phosphonopropionic and phosphonoacetic acids: effect on synthesis of Epstein-Barr virus (EBV) antigens and on transformation of cord blood lymphocytes by EBV. Margalith M; Manor D; Agranat I; Bentor Y; Gelfand T; Goldblum N Cancer Biochem Biophys; 1980; 4(3):137-43. PubMed ID: 6254633 [TBL] [Abstract][Full Text] [Related]
54. Mode of action of acyclovir triphosphate on herpesviral and cellular DNA polymerases. Allaudeen HS; Descamps J; Sehgal RK Antiviral Res; 1982 Aug; 2(3):123-33. PubMed ID: 6291456 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of Epstein-Barr virus replication by a novel L-nucleoside, 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil. Yao GQ; Liu SH; Chou E; Kukhanova M; Chu CK; Cheng YC Biochem Pharmacol; 1996 Apr; 51(7):941-7. PubMed ID: 8651944 [TBL] [Abstract][Full Text] [Related]
56. Unique inhibitory effect of 1-(2'-deoxy-2'-fluoro-beta-L-arabinofuranosyl)-5-methyluracil 5'-triphosphate on Epstein-Barr virus and human DNA polymerases. Kukhanova M; Lin ZY; Yas'co M; Cheng YC Biochem Pharmacol; 1998 Apr; 55(8):1181-7. PubMed ID: 9719472 [TBL] [Abstract][Full Text] [Related]